Arabi, T., Alruwaili, A., Aseafan, M., Almugbel, F., Rauf, M. S., Alzahrani, A. M., Aljubran, A. H., Bazarbashi, S., Alqahtani, A. (2025). Efficacy and safety of second-line lenvatinib after progression on immunotherapy in advanced hepatocellular carcinoma: A systematic review and meta-analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16258